Raymond James Financial Services Advisors’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q4
Sell
-17,070
Closed -$303K 2906
2018
Q3
$303K Sell
17,070
-2,528
-13% -$44.9K ﹤0.01% 2275
2018
Q2
$270K Buy
+19,598
New +$270K ﹤0.01% 2306